Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis
Wei Li, Qingle Li, Yang Jiao, Lingfeng Qin, Rahmat Ali, Jing Zhou, Jacopo Ferruzzi, Richard W. Kim, Arnar Geirsson, Harry C. Dietz, Stefan Offermanns, Jay D. Humphrey, George Tellides
Wei Li, Qingle Li, Yang Jiao, Lingfeng Qin, Rahmat Ali, Jing Zhou, Jacopo Ferruzzi, Richard W. Kim, Arnar Geirsson, Harry C. Dietz, Stefan Offermanns, Jay D. Humphrey, George Tellides
View: Text | PDF
Research Article Cardiology

Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis

  • Text
  • PDF
Abstract

TGF-β is essential for vascular development; however, excess TGF-β signaling promotes thoracic aortic aneurysm and dissection in multiple disorders, including Marfan syndrome. Since the pathology of TGF-β overactivity manifests primarily within the arterial media, it is widely assumed that suppression of TGF-β signaling in vascular smooth muscle cells will ameliorate aortic disease. We tested this hypothesis by conditional inactivation of Tgfbr2, which encodes the TGF-β type II receptor, in smooth muscle cells of postweanling mice. Surprisingly, the thoracic aorta rapidly thickened, dilated, and dissected in these animals. Tgfbr2 disruption predictably decreased canonical Smad signaling, but unexpectedly increased MAPK signaling. Type II receptor–independent effects of TGF-β and pathological responses by nonrecombined smooth muscle cells were excluded by serologic neutralization. Aortic disease was caused by a perturbed contractile apparatus in medial cells and growth factor production by adventitial cells, both of which resulted in maladaptive paracrine interactions between the vessel wall compartments. Treatment with rapamycin restored a quiescent smooth muscle phenotype and prevented dissection. Tgfbr2 disruption in smooth muscle cells also accelerated aneurysm growth in a murine model of Marfan syndrome. Our data indicate that basal TGF-β signaling in smooth muscle promotes postnatal aortic wall homeostasis and impedes disease progression.

Authors

Wei Li, Qingle Li, Yang Jiao, Lingfeng Qin, Rahmat Ali, Jing Zhou, Jacopo Ferruzzi, Richard W. Kim, Arnar Geirsson, Harry C. Dietz, Stefan Offermanns, Jay D. Humphrey, George Tellides

×

Figure 5

Loss of TGF-β signaling induces vascular cell proliferative responses.

Options: View larger image (or click on image) Download as PowerPoint
Loss of TGF-β signaling induces vascular cell proliferative responses.
(...
(A) Immunohistochemistry for BrdU incorporation (brown color, arrows) with hematoxylin counter-staining of nuclei in thoracic aortas of 6-week-old Myh11-CreERT2.Tgfbr2f/f mice treated with vehicle or tamoxifen at 4 weeks of age. Scale bar: 100 μm, BrdU+ medial cells per cross-section, n = 3, ***P < 0.001, t test. (B) Quantitative RT-PCR for Mki67, Ccna2, and Ccnb2; n = 6, **P < 0.01, t test and (C) immunoblotting for total and p-S6K and S6 in thoracic aortas at 6 weeks. (D) Igf1 transcript expression in full-thickness thoracic aortas at 6 weeks; n = 6, P < 0.01, t test or in (E) adventitia (Adv) separated from media (arrows) by laser capture microdissection at 10 weeks; n = 3, **P < 0.01, ***P < 0.001, 1-way ANOVA. (F) Expression of activated S6K, S6, and ERK1/2 in thoracic aortas of KO mice treated with isotype-matched IgG or IGF1 antibody (Ab) at 125 μg/d i.p., q.o.d. from 4–6 weeks or (G) treated with rapamycin (Rapa) at 2 mg/kg/d i.p., q.d. from 3–7 weeks. (H) EVG stains with higher magnification of vessel wall shown in insets. Scale bar: 100 μm and (I) diameter of ascending aortas in 7-week-old mice induced with vehicle or tamoxifen at 3 weeks of age and treated or not with rapamycin as above; n = 10–11, ***P < 0.001, 1-way ANOVA. (J) Aortic dissection rate in these animals; n = 0/11 (vehicle), 10/13 (tamoxifen), and 0/11 (tamoxifen+rapamycin), ***P < 0.001, χ2 test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts